SARS-CoV-2 infection and return to play in junior competitive athletes: is systematic cardiac screening needed?. Issue 5 (29th November 2021)

• Record Type: Journal Article
• Authors: Cavigli, Luna; Cillis, Michele; Mochi, Veronica; Frascaro, Federica; Mochi, Nicola; Hajdarevic, Arnel; Roselli, Alessandra; Capitani, Massimo; Alvino, Federico; Giovani, Silvia; Lisi, Corrado; Cappellini, Maria Teresa; Colloca, Rosa Anna; Mandoli, Giulia Elena; Valente, Serafina; Focardi, Marta; Cameli, Matteo; Bonifazi, Marco; D'Ascenzi, Flavio
• Is Part Of: British journal of sports medicine. Volume 56:Issue 5(2022)
• Page Start: 264
• Page End: 270
• Publication Date: 2021-11-29
• Subjects: athletes -- COVID-19 -- child health -- sports; Sports medicine -- Periodicals; 617.1027
• DOI: 10.1136/bjsports-2021-104764
• Languages: English
• ISSNs: 0306-3674

Abstract

Abstract : Background: SARS-CoV-2 infection might be associated with cardiac complications in low-risk populations, such as in competitive athletes. However, data obtained in adults cannot be directly transferred to preadolescents and adolescents who are less susceptible to adverse clinical outcomes and are often asymptomatic. Objectives: We conducted this prospective multicentre study to describe the incidence of cardiovascular complications following SARS-CoV-2 infection in a large cohort of junior athletes and to examine the effectiveness of a screening protocol for a safe return to play. Methods: Junior competitive athletes suffering from asymptomatic or mildly symptomatic SARS-CoV-2 infection underwent cardiac screening, including physical examination, 12-lead resting ECG, echocardiogram and exercise ECG testing. Further investigations were performed in cases of abnormal findings. Results: A total of 571 competitive junior athletes (14.3±2.5 years) were evaluated. About half of the population (50.3%) was mildly symptomatic during SARS-CoV-2 infection, and the average duration of symptoms was 4±1 days. Pericardial involvement was found in 3.2% of junior athletes: small pericardial effusion (2.6%), moderate pericardial effusion (0.2%) and pericarditis (0.4%). No relevant arrhythmias or myocardial inflammation was found in subjects with pericardial involvement. Athletes with pericarditis or moderate pericardial effusion were temporarily disqualified, and a gradual return to play was achieved after complete clinical resolution. Conclusions: The prevalence of cardiac involvement was low in junior athletes after asymptomatic or mild SARS-CoV-2 infection. A screening strategy primarily driven by cardiac symptoms should detect cardiac involvement from SARS-CoV-2 infection in most junior athletes. Systematic echocardiographic screening is not recommended in junior athletes.